Symbols / SSKN
SSKN Chart
About
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, China, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. It operates through two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company offers XTRAC excimer laser and VTRAC lamp systems, which are used in the treatment of psoriasis, vitiligo, and other skin conditions; and TheraClear acne therapy system for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. It serves dermatologists and dermatological group clinics. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is headquartered in Horsham, Pennsylvania.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Medical Devices | Market Cap | 1.42M |
| Enterprise Value | 10.71M | Income | -10.87M | Sales | 30.98M |
| Book/sh | 0.25 | Cash/sh | 1.20 | Dividend Yield | — |
| Payout | 0.00% | Employees | 106 | IPO | — |
| P/E | — | Forward P/E | -0.19 | PEG | — |
| P/S | 0.05 | P/B | 1.00 | P/C | — |
| EV/EBITDA | -6.07 | EV/Sales | 0.35 | Quick Ratio | 0.70 |
| Current Ratio | 0.95 | Debt/Eq | 1241.40 | LT Debt/Eq | — |
| EPS (ttm) | -2.63 | EPS next Y | -1.29 | EPS Growth | — |
| Revenue Growth | -21.20% | Earnings | 2026-03-25 | ROA | -11.10% |
| ROE | -204.07% | ROIC | — | Gross Margin | 57.74% |
| Oper. Margin | -26.80% | Profit Margin | -35.10% | Shs Outstand | 5.68M |
| Shs Float | 2.89M | Short Float | 9.79% | Short Ratio | 5.32 |
| Short Interest | — | 52W High | 3.86 | 52W Low | 0.12 |
| Beta | 0.32 | Avg Volume | 468.25K | Volume | 120.80K |
| Target Price | — | Recom | Strong_buy | Prev Close | $0.25 |
| Price | $0.25 | Change | 0.40% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$0.23
Latest analyst target
3. DCF / Fair value
$-1.34
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.23
Low
—
High
—
Mean
—
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2025-02-27 | init | Maxim Group | — → Buy | $6 |
| 2023-05-16 | reit | CG Capital | — → Outperform | $4 |
| 2020-11-03 | up | HC Wainwright & Co. | Neutral → Buy | $3 |
| 2020-03-17 | down | HC Wainwright & Co. | Buy → Neutral | — |
| 2019-12-09 | init | Ladenburg Thalmann | — → Buy | $5 |
| 2019-11-21 | init | Oppenheimer | — → Outperform | $7 |
| 2018-12-10 | init | Northland Capital Markets | — → Outperform | $7 |
- SSKN Stock Falls Despite Meta-Analysis Backs Excimer Laser's Efficacy - Yahoo Finance Wed, 18 Feb 2026 14
- Dermatology device maker STRATA Skin exits Nasdaq to cut costs - Stock Titan hu, 19 Feb 2026 21
- $SSKN stock is down 64% today. Here's what we see in our data. - Quiver Quantitative hu, 12 Feb 2026 19
- Market Movers | Winners: NDLS, RXT, SNSE | Losers: SSKN, NAK, OLB - Trefis hu, 19 Feb 2026 04
- Strata Skin Sciences (SSKN) Stock Surges on Laser-Therapy Breakthrough – Buy, Hold or Sell? - TechStock² ue, 14 Oct 2025 07
- Why Is Strata Skin Sciences Stock (SSKN) Up Today? - TipRanks ue, 14 Oct 2025 07
- STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Surges 36% Yet Its Low P/S Is No Reason For Excitement - simplywall.st Sat, 18 Oct 2025 07
- Psoriasis meta-analysis finds up to 85% severity drop with 308 nm laser - Stock Titan ue, 17 Feb 2026 08
- STRATA Skin Sciences Rises 25% Pre-Market — Here's Why - Benzinga Wed, 29 Oct 2025 07
- STRATA Skin Sciences Received Notice of Delisting - TradingView Wed, 11 Feb 2026 08
- STRATA Skin Sciences Confirms Nasdaq Delisting - marketscreener.com hu, 19 Feb 2026 21
- Market Movers | Winners: SCPQ, FGNX, FSLY | Losers: APC, SSKN, QNCX - Trefis Fri, 13 Feb 2026 04
- Strata Skin Sciences to Delist and Go Dark - TipRanks Wed, 11 Feb 2026 08
- Analysts Just Made A Major Revision To Their STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Revenue Forecasts - Yahoo Finance Sat, 16 Aug 2025 07
- STRATA Skin (NASDAQ: SSKN) receives COFEPRIS clearance; first system placed in Mexico City - Stock Titan ue, 28 Oct 2025 07
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 5000 | 7028 | — | Purchase at price 1.40 - 1.41 per share. | RUBINSTEIN SAMUEL | Director | — | 2025-11-18 00:00:00 | D |
| 1 | 14094 | 18804 | — | Sale at price 1.32 - 1.36 per share. | RUBINSTEIN SAMUEL | Director | — | 2025-11-17 00:00:00 | D |
| 2 | 230573 | 723999 | — | Purchase at price 3.14 per share. | GEIGER URI | Director and Beneficial Owner of more than 10% of a Class of Security | — | 2024-07-15 00:00:00 | I |
| 3 | 19100 | 59974 | — | Purchase at price 3.14 per share. | RAFAELI DOLEV | Chief Executive Officer | — | 2024-07-15 00:00:00 | D |
| 4 | 230573 | 723999 | — | Purchase at price 3.14 per share. | ACCELMED PARTNERS, L.P. | Beneficial Owner of more than 10% of a Class of Security | — | 2024-07-15 00:00:00 | D |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | -64.09K | -26.90K | 0.00 | 547.83K |
| TaxRateForCalcs | 0.02 | 0.01 | 0.21 | 0.27 |
| NormalizedEBITDA | 1.02M | -187.00K | 1.13M | -301.00K |
| TotalUnusualItems | -3.86M | -3.19M | 0.00 | 2.03M |
| TotalUnusualItemsExcludingGoodwill | -3.86M | -3.19M | 0.00 | 2.03M |
| NetIncomeFromContinuingOperationNetMinorityInterest | -10.09M | -10.83M | -5.55M | -2.71M |
| ReconciledDepreciation | 5.31M | 5.90M | 5.69M | 4.09M |
| ReconciledCostOfRevenue | 14.48M | 14.90M | 14.39M | 10.13M |
| EBITDA | -2.84M | -3.38M | 1.13M | 1.73M |
| EBIT | -8.15M | -9.28M | -4.56M | -2.36M |
| NetInterestIncome | -1.86M | -1.41M | -837.00K | -299.00K |
| InterestExpense | 2.11M | 1.64M | 926.00K | 314.00K |
| InterestIncome | 242.00K | 231.00K | 89.00K | 15.00K |
| NormalizedIncome | -6.29M | -7.66M | -5.55M | -4.19M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -10.09M | -10.83M | -5.55M | -2.71M |
| TotalExpenses | 38.96M | 39.68M | 40.81M | 34.38M |
| TotalOperatingIncomeAsReported | -9.26M | -8.60M | -4.65M | -4.40M |
| DilutedAverageShares | 3.81M | 3.49M | 3.47M | 3.41M |
| BasicAverageShares | 3.81M | 3.49M | 3.47M | 3.41M |
| DilutedEPS | -2.65 | -3.10 | -1.60 | -0.80 |
| BasicEPS | -2.65 | -3.10 | -1.60 | -0.80 |
| DilutedNIAvailtoComStockholders | -10.09M | -10.83M | -5.55M | -2.71M |
| NetIncomeCommonStockholders | -10.09M | -10.83M | -5.55M | -2.71M |
| NetIncome | -10.09M | -10.83M | -5.55M | -2.71M |
| NetIncomeIncludingNoncontrollingInterests | -10.09M | -10.83M | -5.55M | -2.71M |
| NetIncomeContinuousOperations | -10.09M | -10.83M | -5.55M | -2.71M |
| TaxProvision | -170.00K | -92.00K | 63.00K | 34.00K |
| PretaxIncome | -10.26M | -10.92M | -5.49M | -2.67M |
| OtherIncomeExpense | -3.00M | -3.19M | 2.03M | |
| OtherNonOperatingIncomeExpenses | 864.00K | |||
| SpecialIncomeCharges | -3.86M | -3.19M | 0.00 | 2.03M |
| OtherSpecialCharges | 909.00K | -2.03M | ||
| ImpairmentOfCapitalAssets | 3.86M | 2.28M | 0.00 | |
| NetNonOperatingInterestIncomeExpense | -1.86M | -1.41M | -837.00K | -299.00K |
| InterestExpenseNonOperating | 2.11M | 1.64M | 926.00K | 314.00K |
| InterestIncomeNonOperating | 242.00K | 231.00K | 89.00K | 15.00K |
| OperatingIncome | -5.39M | -6.32M | -4.65M | -4.40M |
| OperatingExpense | 24.48M | 24.78M | 26.42M | 24.25M |
| ResearchAndDevelopment | 883.00K | 1.32M | 1.03M | 1.43M |
| SellingGeneralAndAdministration | 23.59M | 23.46M | 25.39M | 22.82M |
| SellingAndMarketingExpense | 12.29M | 12.96M | 15.30M | 13.11M |
| GeneralAndAdministrativeExpense | 11.30M | 10.51M | 10.09M | 9.71M |
| OtherGandA | 11.30M | 10.51M | 10.09M | 9.71M |
| GrossProfit | 19.08M | 18.46M | 21.77M | 19.85M |
| CostOfRevenue | 14.48M | 14.90M | 14.39M | 10.13M |
| TotalRevenue | 33.56M | 33.36M | 36.16M | 29.98M |
| OperatingRevenue | 33.56M | 33.36M | 36.16M | 29.98M |
| Line Item | 2023-12-31 | |||
|---|---|---|---|---|
| TreasurySharesNumber | 0.00 | |||
| OrdinarySharesNumber | 4.17M | 3.51M | 3.47M | 3.44M |
| ShareIssued | 4.17M | 3.51M | 3.47M | 3.44M |
| NetDebt | 7.93M | 8.26M | 2.04M | |
| TotalDebt | 16.44M | 15.63M | 8.44M | 8.03M |
| TangibleBookValue | -3.03M | -1.15M | -4.37M | 6.53M |
| InvestedCapital | 20.16M | 27.73M | 29.31M | 32.73M |
| WorkingCapital | 1.97M | 3.37M | 1.63M | 7.17M |
| NetTangibleAssets | -3.03M | -1.15M | -4.37M | 6.53M |
| CapitalLeaseObligations | 1.25M | 589.00K | 965.00K | 710.00K |
| CommonStockEquity | 4.97M | 12.69M | 21.83M | 25.41M |
| TotalCapitalization | 20.16M | 27.73M | 29.31M | 32.73M |
| TotalEquityGrossMinorityInterest | 4.97M | 12.69M | 21.83M | 25.41M |
| StockholdersEquity | 4.97M | 12.69M | 21.83M | 25.41M |
| RetainedEarnings | -248.14M | -238.06M | -227.23M | -221.68M |
| AdditionalPaidInCapital | 253.11M | 250.74M | 249.02M | 247.06M |
| CapitalStock | 4.00K | 4.00K | 35.00K | 34.00K |
| CommonStock | 4.00K | 4.00K | 35.00K | 34.00K |
| PreferredStock | 0.00 | 0.00 | 0.00 | 0.00 |
| TotalLiabilitiesNetMinorityInterest | 31.18M | 29.33M | 30.44M | 21.18M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 16.56M | 17.15M | 17.02M | 8.38M |
| OtherNonCurrentLiabilities | 449.00K | 1.69M | 8.62M | 400.00K |
| NonCurrentDeferredLiabilities | 0.00 | 186.00K | 306.00K | 266.00K |
| NonCurrentDeferredRevenue | 314.00K | 400.00K | ||
| NonCurrentDeferredTaxesLiabilities | 0.00 | 186.00K | 306.00K | 266.00K |
| LongTermDebtAndCapitalLeaseObligation | 16.11M | 15.28M | 8.09M | 7.71M |
| LongTermCapitalLeaseObligation | 919.00K | 237.00K | 610.00K | 392.00K |
| LongTermDebt | 15.19M | 15.04M | 7.48M | 7.32M |
| CurrentLiabilities | 14.62M | 12.17M | 13.43M | 12.80M |
| OtherCurrentLiabilities | 1.03M | 53.00K | 313.00K | |
| CurrentDeferredLiabilities | 2.24M | 2.12M | 2.78M | 3.29M |
| CurrentDeferredRevenue | 2.24M | 2.12M | 2.78M | 3.29M |
| CurrentDebtAndCapitalLeaseObligation | 328.00K | 352.00K | 355.00K | 318.00K |
| CurrentCapitalLeaseObligation | 328.00K | 352.00K | 355.00K | 318.00K |
| CurrentNotesPayable | 0.00 | |||
| PensionandOtherPostRetirementBenefitPlansCurrent | 1.78M | 1.68M | 2.00M | 2.05M |
| CurrentProvisions | 180.00K | 136.00K | 59.00K | |
| PayablesAndAccruedExpenses | 9.24M | 7.97M | 7.98M | 7.15M |
| CurrentAccruedExpenses | 441.00K | 311.00K | 572.00K | 628.00K |
| Payables | 8.80M | 7.66M | 7.41M | 6.52M |
| TotalTaxPayable | 6.37M | 4.32M | 3.99M | 3.70M |
| AccountsPayable | 2.43M | 3.34M | 3.42M | 2.82M |
| TotalAssets | 36.16M | 42.02M | 52.27M | 46.59M |
| TotalNonCurrentAssets | 19.56M | 26.47M | 37.22M | 26.62M |
| OtherNonCurrentAssets | 231.00K | 231.00K | 98.00K | 216.00K |
| GoodwillAndOtherIntangibleAssets | 8.01M | 13.84M | 26.20M | 18.89M |
| OtherIntangibleAssets | 5.35M | 7.32M | 17.39M | 10.08M |
| Goodwill | 2.66M | 6.52M | 8.80M | 8.80M |
| NetPPE | 11.32M | 12.40M | 10.93M | 7.52M |
| AccumulatedDepreciation | -26.15M | -24.28M | -21.96M | -19.77M |
| GrossPPE | 37.47M | 36.69M | 32.88M | 27.29M |
| Leases | 87.00K | 203.00K | 136.00K | 254.00K |
| ConstructionInProgress | 2.09M | 3.23M | 2.45M | |
| OtherProperties | 34.75M | 32.72M | 29.77M | 26.59M |
| MachineryFurnitureEquipment | 540.00K | 533.00K | 528.00K | 451.00K |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 16.59M | 15.54M | 15.05M | 19.97M |
| OtherCurrentAssets | 501.00K | 312.00K | 691.00K | 462.00K |
| RestrictedCash | 1.33M | 1.33M | 1.36M | 0.00 |
| PrepaidAssets | 462.00K | |||
| Inventory | 2.25M | 2.67M | 3.10M | 3.49M |
| FinishedGoods | 205.00K | 481.00K | 129.00K | 288.00K |
| RawMaterials | 2.04M | 2.19M | 2.97M | 3.20M |
| Receivables | 5.25M | 4.44M | 4.47M | 3.43M |
| AccountsReceivable | 5.25M | 4.44M | 4.47M | 3.43M |
| AllowanceForDoubtfulAccountsReceivable | -433.00K | -222.00K | -222.00K | -275.00K |
| GrossAccountsReceivable | 5.69M | 4.66M | 4.69M | 3.71M |
| CashCashEquivalentsAndShortTermInvestments | 7.26M | 6.78M | 5.43M | 12.59M |
| CashAndCashEquivalents | 7.26M | 6.78M | 5.43M | 12.59M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -1.45M | -5.54M | -4.66M | -2.15M |
| RepaymentOfDebt | 0.00 | -7.78M | ||
| IssuanceOfDebt | 0.00 | 7.00M | 0.00 | 8.00M |
| IssuanceOfCapitalStock | 1.94M | 0.00 | ||
| CapitalExpenditure | -1.64M | -5.02M | -3.74M | -3.65M |
| InterestPaidSupplementalData | 1.97M | 1.42M | 744.00K | 222.00K |
| IncomeTaxPaidSupplementalData | 23.00K | 22.00K | 19.00K | 0.00 |
| EndCashPosition | 8.60M | 8.12M | 6.79M | 12.59M |
| BeginningCashPosition | 8.12M | 6.79M | 12.59M | 18.11M |
| ChangesInCash | 477.00K | 1.32M | -5.79M | -5.53M |
| FinancingCashFlow | 1.93M | 6.86M | -500.00K | 92.00K |
| CashFlowFromContinuingFinancingActivities | 1.93M | 6.86M | -500.00K | 92.00K |
| NetOtherFinancingCharges | -18.00K | -139.00K | -500.00K | -133.00K |
| ProceedsFromStockOptionExercised | 0.00 | |||
| NetCommonStockIssuance | 1.94M | 0.00 | ||
| CommonStockIssuance | 1.94M | 0.00 | ||
| NetIssuancePaymentsOfDebt | 0.00 | 7.00M | 0.00 | 225.00K |
| NetLongTermDebtIssuance | 0.00 | 7.00M | 0.00 | 225.00K |
| LongTermDebtPayments | 0.00 | -7.78M | ||
| LongTermDebtIssuance | 0.00 | 7.00M | 0.00 | 8.00M |
| InvestingCashFlow | -1.64M | -5.02M | -4.37M | -7.13M |
| CashFlowFromContinuingInvestingActivities | -1.64M | -5.02M | -4.37M | -7.13M |
| NetOtherInvestingChanges | -631.00K | -3.47M | ||
| NetBusinessPurchaseAndSale | -3.47M | |||
| PurchaseOfBusiness | -3.47M | |||
| NetPPEPurchaseAndSale | -1.64M | -5.02M | -3.74M | -3.65M |
| PurchaseOfPPE | -1.64M | -5.02M | -3.74M | -3.65M |
| OperatingCashFlow | 188.00K | -519.00K | -924.00K | 1.51M |
| CashFlowFromContinuingOperatingActivities | 188.00K | -519.00K | -924.00K | 1.51M |
| ChangeInWorkingCapital | 688.00K | -69.00K | -2.88M | 324.00K |
| ChangeInOtherWorkingCapital | -57.00K | -472.00K | -644.00K | -444.00K |
| ChangeInOtherCurrentLiabilities | -319.00K | -376.00K | -477.00K | -369.00K |
| ChangeInPayablesAndAccruedExpense | 1.31M | -297.00K | 832.00K | 1.74M |
| ChangeInAccruedExpense | 2.27M | -197.00K | 229.00K | 1.68M |
| ChangeInPayable | -954.00K | -100.00K | 603.00K | 58.00K |
| ChangeInAccountPayable | -954.00K | -100.00K | 603.00K | 58.00K |
| ChangeInPrepaidAssets | -189.00K | 246.00K | -111.00K | -65.00K |
| ChangeInInventory | 572.00K | 689.00K | -1.34M | -45.00K |
| ChangeInReceivables | -631.00K | 141.00K | -1.15M | -490.00K |
| ChangesInAccountReceivables | -631.00K | 141.00K | -1.15M | -490.00K |
| OtherNonCashItems | 148.00K | 140.00K | 157.00K | 37.00K |
| StockBasedCompensation | 427.00K | 1.30M | 1.47M | 1.64M |
| ProvisionandWriteOffofAssets | -182.00K | -110.00K | 107.00K | 1.00K |
| AssetImpairmentCharge | 4.02M | 2.28M | 0.00 | |
| DeferredTax | -186.00K | -120.00K | 40.00K | 12.00K |
| DeferredIncomeTax | -186.00K | -120.00K | 40.00K | 12.00K |
| DepreciationAmortizationDepletion | 5.31M | 5.90M | 5.69M | 4.09M |
| DepreciationAndAmortization | 5.31M | 5.90M | 5.69M | 4.09M |
| Depreciation | 5.31M | 5.90M | 5.69M | 4.09M |
| OperatingGainsLosses | 49.00K | 981.00K | 52.00K | -1.89M |
| GainLossOnSaleOfPPE | 49.00K | 72.00K | 52.00K | 140.00K |
| NetIncomeFromContinuingOperations | -10.09M | -10.83M | -5.55M | -2.71M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for SSKN
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|